Based on the clinical-pathological classification, breast cancers are grouped as Endocrine receptor-positive type (positive for estrogen receptors or progesterone receptors), HER2-positive type, and triple negative type (TBNC) (negative for estrogen receptors, progesterone receptors, and HER2) [3]. This evidence concerns the gene ERBB2 and breast cancer.